BitVentures Limited Ordinary Shares (BVC)

FairStock Score: 22/100 — RISKY

Key Financials

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

I approach BitVentures with Graham's skepticism and Buffett's preference for understandable, durable businesses. The company describes itself as an early-stage technology developer that also refers clients to financial product partners and offers life, annuity, and critical illness insurance products. That is a thin operating base for a $1.8 billion market capitalization, especially with only six employees. At the 2026-10-13 close of $12.21, FairStock calculates a P/E of 22.61 and a P/B of 7.02. FairStock's ROE is 22.78%, which looks attractive, but return on capital employed is negative at -10.00%, suggesting the core operations are not generating positive returns on invested capital. The debt-to-equity ratio is not provided, so I cannot judge leverage. The Piotroski F-Score is only 1/9, and the FairStock Score is 22/100. Graham's conservative number is $1.05, putting the price at a -1062.86% margin of safety—an enormous premium to asset-based value. No revenue or profit growth figures were provided, and the Lynch category is none because there are only 0 years of filed results; I need at least three to judge consistency. A 52-week range of $0.70 to $18.00 signals extreme price volatility, while a beta of -1.02 is unusual and does not by itself create a moat. Zero dividend yield means no cash return to owners. Without a multi-year record, I cannot establish durable competitive advantages or predict growth. This may be an early-stage story, but the numbers I have do not support a margin of safety. I would need filed financials showing positive operating returns and consistent profits before I could underwrite the equity.

In plain English: BitVentures is a small technology company that develops early-stage tech businesses and refers clients to financial and insurance products. The numbers are mixed: it shows a high return on shareholders' money, but its main operations are not generating positive returns and its financial health score is weak. At $12.21 a share, the price looks expensive compared with its book value and a conservative value estimate of about $1.05 a share.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data as of 2026-10-13 close · note generated 2026-10-15 · model deepseek-flash

Fundamentals from company filings and market-data providers; prices are end-of-day, not real-time. AI-generated analysis is general and educational — not personal investment advice. Scoring methodology · Score test · Disclaimer